NMN vs NR (Nicotinamide Riboside): Choosing the Right NAD+ Precursor
NMN and NR both raise NAD+ — the bioavailability gap is smaller than brands claim. Head-to-head RCT data, cost-per-dose breakdown, and brand picks. MD reviewed.

The Short Version
NR has a longer track record of published human clinical trials and FDA GRAS status through ChromaDex's Niagen. NMN is catching up fast with recent studies showing it effectively raises NAD+ levels in humans. Neither has proven long-term anti-aging benefits in people yet. If you want the more established safety profile, NR is the conservative pick. If you prefer the more direct NAD+ pathway and don't mind newer evidence, NMN is a reasonable choice.
Recommended Products
NMN
NR (Nicotinamide Riboside)
Product recommendations coming soon.
This content is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
Key Differences
| Factor | NMN | NR (Nicotinamide Riboside) |
|---|---|---|
| Pathway to NAD+ | NMN is converted to NAD+ by NMNAT enzymes — one enzymatic step from NAD+ | NR is converted to NMN by NRK1/2 enzymes, then NMN to NAD+ — two enzymatic steps from NAD+ |
| Molecular Size & Cell Entry | Larger molecule (334 Da) — debated whether it enters cells directly or must be converted to NR first via CD73 | Smaller molecule (255 Da) — enters cells via equilibrative nucleoside transporters |
| Human Clinical Evidence | Growing but newer — Yoshino et al. 2021 (n=25), Yi et al. 2023 (n=80), MASADA-NMN 2024 | More established — Martens et al. 2018 (n=24), Elysium NRPT trial 2017 (n=120), Dollerup et al. 2018 (n=40) |
| FDA Regulatory Status | Sold as a supplement but FDA initially challenged its dietary supplement status in 2022; situation has since evolved | GRAS (Generally Recognized as Safe) status through ChromaDex's Niagen since 2016 |
| NAD+ Elevation in Humans | Yoshino et al. 2021 showed 250mg/day raised blood NAD+ metabolites in overweight women (n=25) | Martens et al. 2018 showed 1000mg/day raised blood NAD+ by ~60% in healthy older adults (n=24) |
| Price per Effective Dose | Typically $1.00–$2.50/day for 250–500mg — wide range depending on brand and purity | Typically $1.50–$2.00/day for 300–1000mg Niagen — more standardized pricing |
Best For
People who want the most direct NAD+ precursor pathway and are comfortable with a newer evidence base
People who want the most direct NAD+ precursor pathway and are comfortable with a newer evidence base
Those interested in metabolic health
Yoshino et al. 2021 showed insulin sensitivity improvements
Individuals who prefer flexibility in dosing and sourcing, with multiple brands now offering third-party tested options
Individuals who prefer flexibility in dosing and sourcing, with multiple brands now offering third-party tested options
People who prioritize a longer human safety and efficacy track record
more published RCTs to date
Those who want FDA GRAS-status assurance through ChromaDex's Niagen ingredient
Those who want FDA GRAS-status assurance through ChromaDex's Niagen ingredient
Individuals focused on cardiovascular indicators
Martens et al. 2018 showed a blood pressure trend worth watching
Evidence Snapshot
Both NMN and NR raise NAD+ levels in humans — that much is clear from multiple trials. NR has been studied in more published human RCTs: Martens et al. (J Am Heart Assoc, 2018, n=24) showed a roughly 60% rise in whole-blood NAD+ with favorable blood-pressure trends; Dollerup et al. (Am J Clin Nutr, 2018, n=40) found NR was safe and raised NAD+ but did not improve insulin sensitivity in obese men; Dellinger et al. (NPJ Aging, 2017, n=120) confirmed NAD+ elevation with an NR-containing product. NMN's human evidence is growing, but it is still smaller. Yoshino et al. (Science, 2021, n=25) is the landmark human study showing improved skeletal-muscle insulin signaling in postmenopausal women with prediabetes, and Yi et al. (GeroScience, 2023, n=80) reported NAD+-related biomarker changes alongside physical-performance measures. The honest summary is that both NMN and NR can raise NAD+-related biomarkers, but downstream health benefits in humans remain modestly evidenced rather than proven at scale.
Safety & Interactions
- Pregnancy and breastfeeding: Consult your healthcare provider before taking this supplement during pregnancy or while nursing. The safety of supplemental doses beyond dietary intake has not been established in pregnant or lactating women.
- Blood thinners: If you take blood-thinning medications (e.g., warfarin, apixaban, rivaroxaban, clopidogrel, or high-dose aspirin), consult your healthcare provider BEFORE starting this supplement, as it may have additive antiplatelet or anticoagulant effects.
- Kidney disease: If you have chronic kidney disease (CKD) or any significant kidney impairment, consult your healthcare provider before taking this supplement. Some supplements can accumulate to dangerous levels when kidney function is reduced.
- Gout: Individuals with gout should consult their healthcare provider before starting this supplement. Certain supplements (e.g., collagen, fish oil, niacin) may affect uric acid levels or trigger flares in susceptible individuals.
- Important: This supplement is not a replacement for prescription medications. It is supportive for individuals with low baseline status, not a treatment for diagnosed conditions (anxiety disorders, insomnia, hypertension, osteoporosis, etc.). Do not stop or reduce any prescription without consulting your doctor.
This content is for educational purposes only and is not medical advice. These statements have not been evaluated by the FDA. Always consult your healthcare provider before starting any supplement.
Frequently Asked Questions
Many people stacking NAD+ precursors also use magnesium for sleep, since restorative sleep amplifies the mitochondrial recovery that NMN and NR support.
If your goal is mitochondrial output rather than NAD+ specifically, CoQ10 for energy targets the electron transport chain through a different mechanism than either NMN or NR.
